- Home
- VNDA vs POET Comparison
VNDA vs POET Comparison
Compare VNDA & POET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNDA
- POET
- Stock Information
- Founded
- VNDA 2002
- POET 1972
- Country
- VNDA United States
- POET Canada
- Employees
- VNDA N/A
- POET N/A
- Industry
- VNDA Biotechnology: Pharmaceutical Preparations
- POET Semiconductors
- Sector
- VNDA Health Care
- POET Technology
- Exchange
- VNDA Nasdaq
- POET Nasdaq
- Market Cap
- VNDA 237.9M
- POET N/A
- IPO Year
- VNDA 2006
- POET N/A
- Fundamental
- Price
- VNDA $4.22
- POET $4.42
- Analyst Decision
- VNDA Strong Buy
- POET Strong Buy
- Analyst Count
- VNDA 2
- POET 2
- Target Price
- VNDA $16.50
- POET $6.25
- AVG Volume (30 Days)
- VNDA 500.0K
- POET 541.4K
- Earning Date
- VNDA 05-07-2025
- POET 05-14-2025
- Dividend Yield
- VNDA N/A
- POET N/A
- EPS Growth
- VNDA N/A
- POET N/A
- EPS
- VNDA N/A
- POET N/A
- Revenue
- VNDA $201,351,000.00
- POET $41,427.00
- Revenue This Year
- VNDA $14.36
- POET $9,379.33
- Revenue Next Year
- VNDA $44.53
- POET $684.42
- P/E Ratio
- VNDA N/A
- POET N/A
- Revenue Growth
- VNDA 13.37
- POET N/A
- 52 Week Low
- VNDA $3.85
- POET $1.60
- 52 Week High
- VNDA $6.75
- POET $7.79
- Technical
- Relative Strength Index (RSI)
- VNDA 41.17
- POET 60.61
- Support Level
- VNDA $4.20
- POET $4.10
- Resistance Level
- VNDA $4.64
- POET $4.50
- Average True Range (ATR)
- VNDA 0.17
- POET 0.22
- MACD
- VNDA 0.01
- POET 0.05
- Stochastic Oscillator
- VNDA 20.75
- POET 78.50
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.